A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis | MicrobiomeTrials← Back to trialsNCT07374471
A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis
RecruitingPHASE1, PHASE2INTERVENTIONAL
Trial Details
Start: 2026-04-01Est. Completion: 2028-07
Enrollment target: 100 participants Locations- 2001, Tbilisi, Georgia
- 3001, Chisinau, Moldova
- 4002, Katowice, Poland
- 4001, Warsaw, Poland
- 4003, Wroclaw, Poland
- 1003, Ivano-Frankivsk, Ukraine
- 1001, Kyiv, Ukraine
Other microbiome trials you might be interested in
Recurrent C. Difficile (rCDI)Ulcerative Colitis (UC)Metabolic Syndrome (MetS)
The gut microbiota plays a key role in immunity and metabolism and contributes to diseases such as recurrent C. difficil…
Rome, ItalyEst. completion Jan 19, 2029
Crohn's DiseaseUlcerative Colitis (UC)Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis)
Through a pilot randomized controlled trial (RCT), we aim to test the feasibility and preliminary impact of two online p…
Los Angeles, United StatesEst. completion Jul 2027
Ulcerative Colitis (Disorder)
This multicenter longitudinal observational cohort study aims to characterize objective disease-control trajectories, tr…
Multiple LocationsEst. completion Dec 30, 2031